logo

A middle aged male presented with loss of libido and loss of peripheral vision. LH and testosterone were suppressed.[...]
Every Week the Editor-in-Chief selects an Article of the Week from the current issue of BJUI. The abstract is reproduced below and you can click on the button to read the full arti[...]
The debating halls of learned urological societies often attempt to define theories based on little substance. Unfortunately, although this type of scientific discourse should be e[...]
Every week the Editor-in-Chief selects the Article of the Week from the current issue of BJUI. The abstract is reproduced below and you can click on the button to read the full art[...]
The current issue of the BJUI contains a paper by Dubaja et al. [1] that may be of interest to physicians who have patients with hypogonadism. The authors speak to an unappreciated[...]
The effect of hypogonadism and testosterone-enhancing therapy on alkaline phosphatase and bone mineral density Ali A. Dabaja, Campbell F. Bryson, Peter N. Schlegel and Darius A. Pa[...]
Every week the Editor-in-Chief selects the Article of the Week from the current issue of BJUI. The abstract is reproduced below and you can click on the button to read the full art[...]
Testosterone therapy (TTh) in men with hypogonadism is becoming more commonplace among urologists, endocrinologists and even primary practitioners. While the definition of hypogona[...]
Testosterone Therapy and Cancer Risk Michael L. Eisenberg*†, Shufeng Li*‡, Paul Betts§, Danielle Herder¶, Dolores J. Lamb¶ and Larry I. Lipshultz¶   Departments of *Urology, †[...]
Every week the Editor-in-Chief selects the Article of the Week from the current issue of BJUI. The abstract is reproduced below and you can click on the button to read the full art[...]